Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01965938 · ClinicalTrials.gov registry record · NA
RIFL (Rigid and Flexing Laryngoscope) vs. Fiberoptic Bronchoscope
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT01965938 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 41 participants.
The verdict
NCT01965938, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
We will conduct a randomized trial comparing the success rate and time to intubation using the RIFL vs. the fiberoptic bronchoscope, as the latter is commonly held to be the gold standard of difficult airway devices. Specifically, we wish to compare the of intubation between the two devices in patients with potentially difficult airways as defined by an oropharyngeal class 3-4, BMI greater than 35, or in patients with a history of difficult intubation using direct laryngoscopy.
Interventions
- DEVICE RIFL (Rigid and Flexing Laryngoscope)
- DEVICE Fiberoptic Bronchoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01965938
The ClinicalTrials.gov registry entry for NCT01965938 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which RIFL (Rigid and Flexing Laryngoscope) is the first listed.
NCT01965938 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01965938 about?
NCT01965938 is a clinical study titled "RIFL (Rigid and Flexing Laryngoscope) vs. Fiberoptic Bronchoscope". We will conduct a randomized trial comparing the success rate and time to intubation using the RIFL vs. the fiberoptic bronchoscope, as the latter is commonly held to be the gold standard of difficult airway devices. Specifically, we wish to compare the of intubation between the two devices in patie...
What is the current status of trial NCT01965938?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2012-09. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01965938?
The interventions under investigation include: RIFL (Rigid and Flexing Laryngoscope) (DEVICE), Fiberoptic Bronchoscope (DEVICE).
Who is sponsoring clinical trial NCT01965938?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.